D.E. Shaw & Co’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

D.E. Shaw & Co’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-756,050	Closed	-$2.26M	–	6047
2022 Q1	$2.26M	Buy	756,050 +671,873	+798%	+$1.48M	﹤0.01%	3177
2021 Q4	$108K	Buy	84,177 +54,615	+185%	+$109K	﹤0.01%	5048
2021 Q3	$67K	Sell	29,562 -75,714	-72%	-$272K	﹤0.01%	4782
2021 Q2	$599K	Buy	+105,276	New	+$700K	﹤0.01%	3939
2021 Q1	–	Sell	-11,670	Closed	-$91K	–	4634
2020 Q4	$91K	Sell	11,670 -10,864	-48%	-$96K	﹤0.01%	3825
2020 Q3	$229K	Buy	+22,534	New	+$233K	﹤0.01%	3563

D.E. Shaw & Co's TLMD Position: Q2 2022 in Review

D.E. Shaw & Co sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 756,050 shares — an estimated $2.26M sold.

D.E. Shaw & Co first reported a position in TLMD in Q3 2020 and held it in 6 quarters. The position peaked at $2.26M in Q1 2022. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

D.E. Shaw & Co reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
D.E. Shaw & Co sold 756,050 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $2.26M.
D.E. Shaw & Co first reported a position in SOC Telemed, Inc. Class A Common Stock in Q3 2020 and held it in 6 quarters.
D.E. Shaw & Co's SOC Telemed, Inc. Class A Common Stock position peaked at $2.26M in Q1 2022.
0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.